Author/Authors :
Farajollahi، Mohammad Morad نويسنده Department of Medical Biotechnology, Faculty of Allied Medical Sciences, Tehran University of Medical Sciences, P.O. Box 1449614535, Tehran, I.R. Iran , , Hamzehlou، Sepideh نويسنده Department of Medical Biotechnology, Tehran University of Medical Sciences, Tehran, Iran , , Mehdipour، Ahmad Reza نويسنده , , Samadikuchaksaraei، Ali نويسنده ,
Abstract :
Proteins constitute a group of key molecules with many applications in tissue engineering. Use of proteins provided from natural sources has several limitations which are overcome by the use of recombinant proteins. So far, the recombinant forms of many proteins with tissue engineering applications have been developed including structural proteins, growth factors and cytokines. This technology has enabled the development of specifically designed proteins such as growth factors with matrix binding domains, and hybrid structural proteins with improved mechanical properties. Recombinant proteins are produced either ex vivo or in vivo, by local gene therapy protocols, and are of medical and economic benefits. Due to the high applicability of recombinant proteins in tissue engineering, it is recommended to include this platform as an infrastructural element in any tissue engineering program.
